4.5 Article

miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer

Journal

CANCER BIOLOGY & THERAPY
Volume 7, Issue 2, Pages 255-264

Publisher

TAYLOR & FRANCIS INC
DOI: 10.4161/cbt.7.2.5297

Keywords

microRNA; hypoxia; ovarian cancer

Categories

Funding

  1. Howard Hughes Medical Institute Funding Source: Medline
  2. NCI NIH HHS [P50 CA083638, P01-CA83638] Funding Source: Medline

Ask authors/readers for more resources

cancer pathogenesis. We studied miRNA genes that are regulated by hypoxia in ovarian cancer cell lines by TaqMan miRNA assay containing 157 mature miRNAs. MiR-210 was the most prominent miRNA consistently stimulated under hypoxic conditions. We provide evidence for the involvement of the HIF signaling pathway in miR-210 regulation. Biocomputational analysis and in vitro assays demonstrated that e2f transcription factor 3 (e2f3), a key protein in cell cycle, is regulated by miR-210. E2F3 was further confirmed to be downregulated at the protein level upon induction of miR-210. Importantly, we found remarkably high frequency of miR-210 gene copy deletions in ovarian cancer patients (64%, n = 114) and that gene copy number correlates with miR-210 expression levels. Taken together, our results indicate that miR-210 plays a crucial role in tumor onset as a key regulator of the hypoxia response and provide evidence for a link between hypoxia and the regulation of cell cycle.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available